WallStreetZenWallStreetZen

NASDAQ: LXRX
Lexicon Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for LXRX

Based on 2 analysts offering 12 month price targets for Lexicon Pharmaceuticals Inc

Min Forecast
$3.10+27.57%
Avg Forecast
$4.55+87.24%
Max Forecast
$6.00+146.91%

Should I buy or sell LXRX stock?

Based on 2 analysts offering ratings for Lexicon Pharmaceuticals Inc.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although LXRX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates LXRX as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -6.47% per year. Learn More

Be the first to know when Wall Street analysts revise their LXRX stock forecasts and price targets.

LXRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-05-11
lockedlocked$00.00+00.00%2026-03-23

1 of 1

Forecast return on equity

Is LXRX forecast to generate an efficient return?

Company
-7.8%
Industry
76.32%
Market
171.51%
LXRX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is LXRX forecast to generate an efficient return on assets?

Company
-5.44%
Industry
38.75%
LXRX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LXRX earnings per share forecast

What is LXRX's earnings per share in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
-$0.16
Avg 2 year Forecast
-$0.21
Avg 3 year Forecast
-$0.09

LXRX revenue forecast

What is LXRX's revenue in the next 3 years based on estimates from 7 analysts?

Avg 1 year Forecast
$38.9M-6.13%
Avg 2 year Forecast
$20.6M-50.43%
Avg 3 year Forecast
$77.7M+87.32%
LXRX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LXRX revenue growth forecast

How is LXRX forecast to perform vs Biotechnology companies and vs the US market?

Company
16.22%
Industry
33.17%
Market
13.45%
LXRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LXRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LXRX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LXRX$2.43$4.55+87.24%Strong Buy
GERN$1.63N/AN/A
AVTX$19.47$45.73+134.86%Strong Buy
EYPT$13.05$44.50+241.00%Strong Buy
SANA$3.79$7.00+84.70%Buy
View Top Biotech Stocks

Lexicon Pharmaceuticals Stock Forecast FAQ

Is Lexicon Pharmaceuticals Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: LXRX) stock is to Strong Buy LXRX stock.

Out of 2 analysts, 1 (50%) are recommending LXRX as a Strong Buy, 1 (50%) are recommending LXRX as a Buy, 0 (0%) are recommending LXRX as a Hold, 0 (0%) are recommending LXRX as a Sell, and 0 (0%) are recommending LXRX as a Strong Sell.

If you're new to stock investing, here's how to buy Lexicon Pharmaceuticals stock.

What is LXRX's earnings growth forecast for 2026-2028?

(NASDAQ: LXRX) Lexicon Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.99%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 30.88%.

Lexicon Pharmaceuticals's earnings in 2026 is -$61,117,000.On average, 7 Wall Street analysts forecast LXRX's earnings for 2026 to be -$72,883,782, with the lowest LXRX earnings forecast at -$78,490,227, and the highest LXRX earnings forecast at -$70,080,560. On average, 7 Wall Street analysts forecast LXRX's earnings for 2027 to be -$94,508,640, with the lowest LXRX earnings forecast at -$118,180,296, and the highest LXRX earnings forecast at -$56,064,448.

In 2028, LXRX is forecast to generate -$41,647,875 in earnings, with the lowest earnings forecast at -$74,129,659 and the highest earnings forecast at $28,032,224.

What is LXRX's revenue growth forecast for 2026-2028?

(NASDAQ: LXRX) Lexicon Pharmaceuticals's forecast annual revenue growth rate of 16.22% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 33.17%, and while it is forecast to beat the US market's average forecast revenue growth rate of 13.45%.

Lexicon Pharmaceuticals's revenue in 2026 is $41,469,000.On average, 7 Wall Street analysts forecast LXRX's revenue for 2026 to be $17,321,689,555, with the lowest LXRX revenue forecast at $13,561,366,956, and the highest LXRX revenue forecast at $20,930,727,135. On average, 7 Wall Street analysts forecast LXRX's revenue for 2027 to be $9,146,514,179, with the lowest LXRX revenue forecast at $0, and the highest LXRX revenue forecast at $27,331,418,246.

In 2028, LXRX is forecast to generate $34,564,621,909 in revenue, with the lowest revenue forecast at $3,183,214,752 and the highest revenue forecast at $69,159,500,822.

What is LXRX's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: LXRX) forecast ROA is -5.44%, which is lower than the forecast US Biotechnology industry average of 38.75%.

What is LXRX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year LXRX price target, the average LXRX price target is $4.55, with the highest LXRX stock price forecast at $6.00 and the lowest LXRX stock price forecast at $3.10.

On average, Wall Street analysts predict that Lexicon Pharmaceuticals's share price could reach $4.55 by May 11, 2027. The average Lexicon Pharmaceuticals stock price prediction forecasts a potential upside of 87.24% from the current LXRX share price of $2.43.

What is LXRX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: LXRX) Lexicon Pharmaceuticals's current Earnings Per Share (EPS) is -$0.15. On average, analysts forecast that LXRX's EPS will be -$0.16 for 2026, with the lowest EPS forecast at -$0.18, and the highest EPS forecast at -$0.16. On average, analysts forecast that LXRX's EPS will be -$0.21 for 2027, with the lowest EPS forecast at -$0.27, and the highest EPS forecast at -$0.13. In 2028, LXRX's EPS is forecast to hit -$0.09 (min: -$0.17, max: $0.06).

What is LXRX's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: LXRX) forecast ROE is -7.8%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.